fda glp-1 news november 2025 GLP-1s in 2026: What Brokers Need to Know New GLP-1 Pill Foundayo (Orforglipron)

In many studies, these agents have also been associated with reductions in blood pressure, although the extent to which this effect depends directly on weight loss has remained less clearly defined

Like if somebody is like, Uh, like, you know, they're criticizing this

Ozempic was first approved by the FDA in 2017 as a diabetes treatment and its use, alongside other GLP-1 agonist medications, has been in the spotlight in recent years

Recent activity continues to center on discovery and trial-readiness issues rather than new JPML action

Keep protein shakes on hand On days when solid food is unappealing, a protein shake can deliver 3040 grams of protein in a form that is easier to consume

Some users report slightly altered stool consistency during the first few days, which typically normalizes quickly